🔗 Share this article

While America proceeds with unprecedented revisions to its vaccination recommendations, a particular individual appears in a surprising turn: Dr. Tracy Beth Høeg, a US-based sports medicine doctor and public health researcher who initially gained attention by expressing skepticism about coronavirus vaccinations in the pandemic and has focused upon potential fatalities following COVID-19 vaccination in her recent position at the FDA.

Proposed Shifts to Pediatric Vaccine Schedule

Public health authorities planned to unveil major changes to the childhood immunization program in December, synchronizing the US with Denmark’s immunization schedule, it is understood – a substantial departure that would put the US at odds with a large portion of the international standard with little proof for improved outcomes. This reveal has been pushed back until the next year.

Instead of the top vaccines chief, Dr. Høeg is listed to speak at the gathering. She was recently named acting director of the FDA’s CDER, the fifth appointee to lead the center this calendar year.

A New Direction at the FDA

This interim role might represent a strengthened alliance between the drug and biologics branches as Dr. Høeg and Prasad strengthen their influence at the regulatory agency – and it suggests a renewed priority upon dismantling long-standing vaccines at the FDA.

Høeg has often pushed for halting certain childhood vaccine recommendations in the US to become more similar to Denmark, a nation with universal health coverage and a population roughly the population of Wisconsin’s.

So far statements, she has continued to focus on vaccines – usually the domain of Dr. Prasad, head of the FDA’s vaccine center – rather than medication approval.

Doubts Over Expertise

Høeg has no apparent background in drug development, regulation or administrative roles, which has been standard for past leaders of the CBER. She has been employed at the FDA as a top consultant to the FDA chief and CBER since March.

“It seems she lacks to have the requisite experience” for leading the CDER, stated Jonathan Howard. “She’s never run a clinical trial. She has no expertise in leading a large organization. She has no expertise in pharmaceutical oversight.”

Former directors of the center would “be deeply familiar with legal statutes and the research of medication creation”, commented a former acting FDA commissioner. “Clearly, she has not acquired the sort of resume that former directors who led the center have had.”

This division has an immense workload at the agency, Woodcock emphasized.

“Everybody just pays attention on the innovative therapies, but the off-patent medication office authorizes thousands of generic drugs. There’s a biosimilars program, OTC medication office and more, and all of those must be supervised,” Dr. Woodcock noted. “The area you neglect, that is the part that I always told people is going to bite you.”

Additionally, a substantial administrative component to the role, which supervises more than 5,000 employees. “It’s a massive administrative position, if you perform it correctly,” she said.

Agency Reaction and Controversial Policies

When asked about concerns about Høeg’s fitness for the role and whether this selection represents more teamwork among FDA leaders on vaccines, a representative stated that the “questions stem from flawed premises”.

“Her resume is consistent with the duties of her job,” the representative said, noting the period Høeg spent guiding the agency head on “medication safety and approval science, including computerized risk analysis and shot safety tracking”.

In her interim role, Høeg takes over the commissioner’s recently launched expedited review system, a controversial one-day medication authorization process that reportedly worried her predecessors. “By what process are these therapies being selected for this voucher program? Who is making the calls?” Howard said. “There’s a lot of lack of transparency going on at the FDA right now.”

In general, he said, “the agency appears to be shifting towards more relaxed regulations of all drugs, except for vaccines.”

Documented History on Vaccines

Concerning vaccines, Dr. Høeg has a more established, if troubling, track record, Howard have noted. She published a study using unconfirmed volunteer-provided data to estimate the incidence of myocarditis following Covid vaccination. She consulted for the Florida chief medical officer Dr. Joseph Ladapo, who reportedly have modified findings to suggest COVID-19 vaccines are more dangerous than they are.

Among her “desired changes” for the current administration featured changing guidelines for novel immunizations and halting “unnecessary” immunizations, she said post-election on a audio program. At the agency, Dr. Høeg has according to sources suggested barring teenage boys from getting COVID-19 vaccinations.

“She’s an all-around ideologue who starts off with her preconceived notions and reverse-engineers to retrofit the evidence in a highly deceptive, fraudulent manner,” Howard stated.

Taking Control and a “Campaign of Retribution”

Høeg became part of other skeptics, {like|